ProPublica HIPAA Helper or HIPAA Wall of Shame
ProPublica, the same organization who brought us "Dollars for Docs" and the "Surgeon Scorecard," is once again making a…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
January 2016
Another Transparency Threat – Health Education Exchanges and Medical…
We have previously drawn attention to some of the downsides of transparency as it relates to medical information. Those…
FDA CDER Update 2016
We recently reported that 2015 resulted in the highest level of newly approved U.S. drugs in nineteen years. This…
Senators Wyden and Grassley Request Public Comments on Gilead Pricing
On the heels of their December 1, 2015, report on Gilead Sciences' pricing of Hepatitis C drugs Sovaldi and Harvoni,…
CMS Final Rule on Covered Outpatient Drugs
The Centers for Medicare & Medicaid Services (CMS) issued the Covered Outpatient Drugs final rule with comment on…
Office of Management and Budget To Revise Fraud Rules by Spring
The White House Office of Management and Budget released their 2016 rule agenda at the close of last year, laying out…
Improving Regulatory Transparency for New Medical Therapies Act
President Obama recently signed the Improving Regulatory Transparency for New Medical Therapies Act into law. The Act…
CME Saves in Overall Healthcare Cost
We have long been vocal proponents of Continuing Medical Education (CME) and the benefits it provides to both the medical…
Washington, D.C. Changes Pharmaceutical Detailer License Requirements
Pharmaceutical and life sciences companies have long used detailing as a way to effectively communicate the benefits and…
Problems Abound with Ohio Drug Price Ballot Petition
As you may recall, we have previously written about ballot initiatives in California and Ohio that are attempting to…